Cardinal Health Non-US — Revenue decreased by 2.8% to $423.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.0%, from $399.00M to $423.00M. Over 3 years (FY 2021 to FY 2025), Non-US — Revenue shows a downward trend with a -29.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful international expansion or strong demand in foreign markets, while a decrease may indicate competitive pressure, unfavorable currency translation, or strategic divestment from global regions.
This metric represents the total net sales generated by the company's operations located outside of its primary domestic...
Peers in the pharmaceutical wholesale industry often report international revenue as a distinct geographic segment to highlight exposure to global healthcare spending and emerging market growth.
cah_segment_non_us_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.26B | $1.13B | $1.08B | $1.13B | $1.18B | $1.13B | $1.14B | $1.17B | $1.21B | $1.21B | $1.21B | $1.22B | $408.00M | $428.00M | $399.00M | $434.00M | $419.00M | $435.00M | $423.00M |
| QoQ Change | — | -10.2% | -4.6% | +4.9% | +4.7% | -4.6% | +0.7% | +2.6% | +3.3% | +0.2% | -0.2% | +0.7% | -66.4% | +4.9% | -6.8% | +8.8% | -3.5% | +3.8% | -2.8% |
| YoY Change | — | — | — | — | -6.0% | -0.1% | +5.5% | +3.2% | +1.9% | +7.1% | +6.2% | +4.2% | -66.3% | -64.5% | -67.2% | — | +2.7% | +1.6% | +6.0% |